| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a1ad6ca6aae359da4b470263c30c093 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
2001-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bf997bf697ccfdca11b9c9f7fd89958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8446bf349fd7e9aafdbafac2f3ef13c1 |
| publicationDate |
2002-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02071844-A1 |
| titleOfInvention |
Heterocyclic hydroxamic acid derivatives as mmp inhibitors |
| abstract |
Novel MMP inhibitor compositions comprising heterocyclic hydroxamic acid derivatives of formula: (I) These compounds are useful in the treatment of diseases and conditions in which matrix metalloproteinases are involved, such as cancer, arthritis, tumor metastasis and multiple sclerosis. |
| priorityDate |
2001-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |